Detalhe da pesquisa
1.
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers.
Mol Cell Proteomics
; 22(7): 100580, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37211046
2.
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
J Clin Oncol
; 41(15): 2682-2690, 2023 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37196429
3.
Tumor cell expression of heat shock protein (HSP) 72 is influenced by HSP72 [HSPA1B A(1267)G] polymorphism and predicts survival in small Cell lung cancer (SCLC) patients.
Cancer Invest
; 30(4): 317-22, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22468780
4.
[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer]. / A cisplatin okozta nefrotoxicitás elofordulása, kockázati tényezoi és megelozése tüdokarcinómás betegekben.
Magy Onkol
; 54(4): 289-96, 2010 Dec.
Artigo
Húngaro
| MEDLINE | ID: mdl-21163759
5.
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
J Mol Diagn
; 10(2): 160-8, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18258923
6.
[The role of adjuvant chemotherapy in the treatment of non-small cell lung cancer]. / Az adjuváns kemoterápia helye a nem kissejtes tüdorák kezelésében.
Magy Onkol
; 50(3): 229-32, 2006.
Artigo
Húngaro
| MEDLINE | ID: mdl-17099782
7.
OVERVIEW OF A DIGITAL TOMOSYNTHESIS DEVELOPMENT: NEW APPROACHES FOR LOW-DOSE CHEST IMAGING.
Radiat Prot Dosimetry
; 169(1-4): 171-6, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26564865
8.
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
J Clin Oncol
; 22(9): 1589-97, 2004 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15117980
9.
Efficacy of gemcitabine--cisplatin treatment in stage IIIA ("bulky"N2), IIIB and IV non-small cell lung cancer.
Anticancer Res
; 25(1B): 471-5, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15816614
10.
Inhibition of EGFR tyrosine-kinase in NSCLC treatment: the Hungarian experience with gefitinib in the context of an expanded access programme.
Anticancer Res
; 25(6C): 4759-62, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16334173
11.
[New therapies for non-small cell lung cancer]. / Uj terápiás lehetoségek a nem kissejtes tüdorák kezelésében.
Orv Hetil
; 146(21): 1135-41, 2005 May 22.
Artigo
Húngaro
| MEDLINE | ID: mdl-15991677
12.
[Chemotherapy of small cell lung cancer] / A kissejtes tüdôrák kemoterápiája.
Magy Onkol
; 44(3): 221-225, 2000 Oct 01.
Artigo
Húngaro
| MEDLINE | ID: mdl-12050750
13.
[Effectiveness of Gemzar-Cisplatin therapy in stage IIIA-N2, IIIB and IV non-small cell lung cancer]. / A Gemzar+Cisplatin kezelés hatékonysága a nem kissejtes tüdôrák IIIA-N2, IIIB és IV-es stádiumában.
Magy Onkol
; 47(2): 185-8, 2003.
Artigo
Húngaro
| MEDLINE | ID: mdl-12975667